- 睿昂基因 (688217)- 筹资活动产生的现金流量

现金流分析步骤三:分析 筹资活动 产生的现金流量

现金及等价物净增加额

-0.0亿    ,0.8,0.2,-0.3,0.1,-0.1,0.8,-0.5,-0.0
了解明细
期初现金及等价物余额

1.6亿    ,0.6,1.4,1.6,1.3,1.3,1.2,2.0,1.6
了解明细
期末现金及等价物余额

1.5亿    ,1.4,1.6,1.3,1.3,1.2,2.0,1.6,1.5
了解明细


经营活动现金流净额

0.1亿    ,0.1,-0.0,0.1,0.7,0.8,0.7,0.5,0.1
了解明细
投资活动现金流净额

0.0亿    ,-1.4,-0.9,-0.4,-0.5,-2.8,0.1,-1.0,0.0
了解明细
筹资活动现金流净额

-0.2亿    ,2.2,1.0,-0.1,-0.1,1.9,-0.0,0.1,-0.2
了解明细
汇率变动对现金影响

0.0亿    ,0.0,0.1,0.0,-0.0,-0.0,0.0,0.0,0.0
了解明细


筹资活动现金流入小计

0亿    ,2.6,1.1,0,0.0,2.2,0.0,0.3,0
了解明细
筹资活动现金流出小计

0.2亿    ,0.5,0.0,0.1,0.1,0.3,0.1,0.2,0.2
了解明细
取得借款收到的现金

0亿    ,0,0.1,0,0,0,0.0,0.2,0
了解明细
偿还债务支付的现金

0.0亿    ,0,0,0.1,0,0,0,0.0,0.0
了解明细
吸收投资收到的现金

0亿    ,2.6,1.0,0,0.0,2.2,0,0.1,0
了解明细
分配股利、利息的现金

0.0亿    ,0,0.0,0,0,0.0,0.0,0.1,0.0
了解明细
收到其他筹资有关的现金

0亿    ,0,0,0,0,0,0,-0.0,0
了解明细
支付其他筹资有关的现金

0.2亿    ,0.5,0.0,0.0,0.1,0.3,0.1,0.0,0.2
了解明细
发行债券收到的现金

0亿    ,0,0,0,0,0,0,0,0
了解明细